USA - NASDAQ:AXGN - US05463X1063 - Common Stock
We assign a fundamental rating of 5 out of 10 to AXGN. AXGN was compared to 190 industry peers in the Health Care Equipment & Supplies industry. AXGN has only an average score on both its financial health and profitability. AXGN has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -2.27% | ||
ROE | -4.15% | ||
ROIC | 0.75% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 0.84% | ||
PM (TTM) | N/A | ||
GM | 74.27% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.43 | ||
Debt/FCF | 13.85 | ||
Altman-Z | 4.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.14 | ||
Quick Ratio | 2.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 73.33 | ||
Fwd PE | 36.45 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 233.7 | ||
EV/EBITDA | 86.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
17.6
+0.4 (+2.33%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 73.33 | ||
Fwd PE | 36.45 | ||
P/S | 3.98 | ||
P/FCF | 233.7 | ||
P/OCF | 112.67 | ||
P/B | 7.21 | ||
P/tB | 7.63 | ||
EV/EBITDA | 86.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -2.27% | ||
ROE | -4.15% | ||
ROCE | 0.95% | ||
ROIC | 0.75% | ||
ROICexc | 0.9% | ||
ROICexgc | 0.94% | ||
OM | 0.84% | ||
PM (TTM) | N/A | ||
GM | 74.27% | ||
FCFM | 1.7% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.43 | ||
Debt/FCF | 13.85 | ||
Debt/EBITDA | 5.16 | ||
Cap/Depr | 49.09% | ||
Cap/Sales | 1.83% | ||
Interest Coverage | 0.24 | ||
Cash Conversion | 77.33% | ||
Profit Quality | N/A | ||
Current Ratio | 4.14 | ||
Quick Ratio | 2.67 | ||
Altman-Z | 4.56 |